中文名稱:化合物 PF-2771 | 英文名稱:PF-2771 |
CAS:2070009-55-9 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號(hào): T12434 |
Name | PF-2771 |
Description | PF-2771 is a potent and selective centromere protein E (CENP-E) inhibitor. PF-2771 inhibits CENP-E motor activity with an IC 50 of 16.1 nM. PF-2771 is used as an anticancer agent. |
In vitro | PF-2771 is a potent and selective CENP-E inhibitor, inhibiting CENP-E motor activity with an IC 50 of 16.1 nM. PF-2771 shows no inhibitory effect on the ATPase activities of highly related kinesins (0% inhibition of Eg5/KSP, chromokinesin, and MCAK at both 1 or 10 μM PF-2771). PF-2771 exhibits inactive activity against 74 protein kinases (all < 23% inhibition with 1 μM PF-2771, < 40% with 10 μM PF-2771). PF-2771 is cytotoxic to the basal-like breast cancer tumor cell survival, with EC 50 s of < 0.1 μM, and with no cytotoxicity on the normal and premalignant cell lines (EC 50 > 5 μM). PF-2771 (100 nM) causes a chromosomal congression defect in MDA-MB-468 cells [1]. |
In vivo | PF-2771 (100 mg/kg, every day i.p.) potently inhibits CENP-E motor function, and leads to tumor regression in SCID mice bearing AA1077 mammary tumors [1]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 32 mg/mL (57.75 mM) |
Keywords | PF 2771 | PF2771 | PF-2771 |
Inhibitors Related | S-trityl-L-Cysteine | Paprotrain | Eg5-IN-1 | Empesertib | UMK57 | BRD9876 | CW-069 | SB-743921 hydrochloride | Eg5 Inhibitor V, trans-24 | BAY1217389 | AZD-4877 | MPI-0479605 |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP6年
|
上海澤葉生物科技有限公司
|
2025-02-08 | |
詢價(jià) |
VIP2年
|
陜西西化化學(xué)工業(yè)有限公司
|
2024-07-24 | |
詢價(jià) |
VIP3年
|
武漢英諾醫(yī)藥科技有限公司
|
2025-02-08 |